SCHEMBL23635973

SCHEMBL23635973

COc1ccc(C(F)(F)F)cc1-c1nnc(NS(=O)(=O)c2c(OC)cccc2OC)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 11/20 0.45
ALPL P05186 2/20 0.43
SCN5A Q14524 2/20 0.42
KDM4E B2RXH2 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
AHR P35869 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
AMY1A P0DUB6 1/20 0.41
MEN1 O00255 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
USP2 O75604 1/20 0.40
USP8 P40818 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23292605 0.84 KMT2A (0.48) KDM4ENPC1RAB9AALDH1A1HPGD
SCHEMBL27097756 0.83 KDM4E (0.59) SCN9AKDM4ENPC1RAB9AALDH1A1
SCHEMBL27097779 0.79 MAPT (0.48) SCN9AALPLSCN5AMEN1ALOX15
SCHEMBL23292636 0.77 KDM4E (0.51) KDM4ENPC1RAB9AALDH1A1HPGD
SCHEMBL23635971 0.76 MEN1 (0.46) KDM4ENPC1RAB9AALDH1A1HPGD
SCHEMBL23635965 0.76 KDM4E (0.52) KDM4ENPC1RAB9AALDH1A1HPGD
SCHEMBL23635977 0.75 RXFP1 (0.46) SCN9AKDM4ENPC1RAB9AALDH1A1
SCHEMBL23635980 0.75 AMY1A (0.50) KDM4ENPC1RAB9AALDH1A1HPGD
SCHEMBL23635961 0.75 KDM4E (0.44) SCN9AKDM4ENPC1RAB9AALDH1A1
SCHEMBL23635944 0.73 KDM4E (0.53) KDM4ENPC1RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240277683-A1 COMPOUNDS CTXT PTY LTD (AU) 2024-08-22 US disclosed
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-20210213004-A1 Compounds CTXT PTY LTD (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240277683-A1 COMPOUNDS SLC10A1, ABCB11, REN SCN9A 172/4885ALPL 953/4885SCN5A 152/4885
US-20210213004-A1 Compounds SLC10A1, ABCB11, REN SCN9A 163/4885ALPL 1275/4885SCN5A 165/4885
US-11911372-B2 Compounds SLC10A1, ABCB11, REN SCN9A 163/4885ALPL 1275/4885SCN5A 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.